
Sign up to save your podcasts
Or
In this week's episode we’ll learn about the role of interleukin-1 signaling in the bone marrow microenvironment in the development of myelodysplastic syndromes, the immune checkpoint regulator VISTA as a potential target for preventing graft-vs-host disease, and epcoritamab plus gemcitabine and oxaliplatin in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma.
Featured Articles:
4.1
4646 ratings
In this week's episode we’ll learn about the role of interleukin-1 signaling in the bone marrow microenvironment in the development of myelodysplastic syndromes, the immune checkpoint regulator VISTA as a potential target for preventing graft-vs-host disease, and epcoritamab plus gemcitabine and oxaliplatin in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma.
Featured Articles:
127 Listeners
73 Listeners
320 Listeners
26 Listeners
480 Listeners
91 Listeners
1,088 Listeners
175 Listeners
745 Listeners
515 Listeners
318 Listeners
365 Listeners
2 Listeners
165 Listeners
48 Listeners